Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates

Transplantation

Volumn 72, Issue 3, 2001, Pages 377-384

  Kirk, Allan D ^a,b,d   Tadaki, Douglas K ^a   Celniker, Abbie ^c   Scott Batty, D ^b   Berning, Justin D ^a   Colonna, John O ^a,b   Cruzata, Francis ^a   Elster, Eric A ^a   Gray, Gary S ^c   Kampen, Robert L ^a   Patterson, Noelle B ^a   Szklut, Pam ^c   Swanson, John ^b   Xu, He ^a   Harlan, David M ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

^d Building 10 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LIGAND; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B7; MONOCLONAL ANTIBODY CD86; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG TOLERABILITY; KIDNEY ALLOGRAFT REJECTION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; T LYMPHOCYTE;

EID: 0035882129     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200108150-00005     Document Type: Article

References (24)

1. CD28/B7 system of T cell costimulation
2. The B7 and CD28 receptor families
3. CD28/B7 costimulation: A review
4. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig
5. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo
6. Transplantation tolerance induced by CTLA4-Ig
7. Preventing allograft rejection with CTLA4IG: Effect of donor-specific transfusion route or timing
8. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: Inhibition of cell-mediated and humoral immune responses in vivo
9. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
10. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation
11. Prolongation of cardiac graft survival with anti-CD4Ig plus hCTLA4Ig in primates
12. The role of donor and recipient B7-1 (CD80) in allograft rejection
13. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts
14. Prolonged skin graft survival by administration of anti-CD80 monoclonal antibody with cyclosporin A
15. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway
16. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival
17. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics
18. Human B7-1 is more efficient than B7-2 in providing co-stimulation for alloantigen-specific T cells
19. High-resolution HLA-DRB typing using denaturing gradient gel electrophoresis and direct sequencing
20. Humanized anti-CD154 monoclonal antibody treatment prevents acute renal allograft rejection in non-human primates
21. Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection
22. Post-transplant diastolic hypertension: Associations with intragraft TGF-β, endothelin and renin transcription
23. Primate allotransplantaton using costimulation blockade
24. Transplant tolerance: A look at the non-human primate literature in the view of modern tolerance theories